Evofem Biosciences to Report Second Quarter 2021 Results and Provide Corporate Update on Wednesday, August 11, 2021
SAN DIEGO, July 28, 2021 /PRNewswire/ -- Evofem Biosciences, Inc., (NASDAQ:EVFM) will hold a webcast and conference call to discuss financial results and business highlights for the second quarter endedJune 30, 2021on Wednesday, August 11, 2021 at 4:30 p.m.
- SAN DIEGO, July 28, 2021 /PRNewswire/ -- Evofem Biosciences, Inc., (NASDAQ:EVFM) will hold a webcast and conference call to discuss financial results and business highlights for the second quarter endedJune 30, 2021on Wednesday, August 11, 2021 at 4:30 p.m.
- The webcast (live and archived) and related slide presentation can be accessed through https://evofem.investorroom.com/2021Q2Results or directly at https://edge.media-server.com/mmc/p/h6zpy9h5 .
- Atelephone replay will be available for 24 hours after the call at(855) 859-2056 (U.S.) or(404) 537-3406 (International), conference ID 9190716.
- The Company launched its first FDA-approved commercial product, Phexxi (lactic acid, citric acid and potassium bitartrate), inthe United StatesinSeptember 2020.